Tezosentan Attenuates Organ Injury and Mesenteric Blood Flow Decrease in Endotoxemia and Cecal Ligation and Puncture

Journal of Surgical Research

Volumn 141, Issue 2, 2007, Pages 211-219

  Erdem, Aysen ^a   Meltem Sevgili, A ^a   Akbiyik, Filiz ^a   Atilla, Pergin ^a   Cakar, Nur ^a   Balkanci, Z Dicle ^a   Iskit, Alper B ^a   Guc, M Oguz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

doppler flowmeter; endothelin; mesenteric ischemia; septic shock; tezosentan

Indexed keywords

ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ESCHERICHIA ENTEROTOXIN; GLUTATHIONE; MYELOPEROXIDASE; SODIUM CHLORIDE; TEZOSENTAN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CECUM LIGATION; CONTROLLED STUDY; DOPPLER FLOWMETER; DRUG MECHANISM; ENDOTOXEMIA; HISTOPATHOLOGY; KIDNEY INJURY; LIVER PROTECTION; MESENTERY BLOOD FLOW; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SEPTIC SHOCK; SPLEEN INJURY;

ANIMALS; ENDOTOXEMIA; KIDNEY; LIVER; MICE; PEROXIDASE; PYRIDINES; RECEPTORS, ENDOTHELIN; SHOCK, SEPTIC; SPLANCHNIC CIRCULATION; SPLEEN; TETRAZOLES;

EID: 34447270217     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.08.028     Document Type: Article

References (43)

1. Rangel-Frausto M.S., Pittet D., Costigan M., et al. The natural history of the systemic inflammatory response syndrome (SIRS). J Am Med Assoc 273 (1995) 117
2. Kavuklu B., Iskit A.B., Guc M.O., et al. Aminoguanidine attenuates endotoxin-induced mesenteric vascular hyporeactivity. Br J Surg 87 (2000) 448
3. Guc M.O., Gray G.A., Furman B.L., et al. Endotoxin-induced impairment of vasodepressor responses in the pithed rat. Eur J Pharmacol 204 (1991) 63
4. Bone R.C. The pathogenesis of sepsis. Ann Intern Med 115 (1991) 457
5. Parrillo J.E. The cardiovascular pathology of sepsis. Annu Rev Med 40 (1989) 469
6. Baykal A., Iskit A.B., Kaynaroglu V., et al. Effects of adrenaline or endotoxin tolerance states on mesenteric blood flow in endotoxaemia. Aust NZ J Surg 69 (1999) 134
7. Iskit A.B., Senel I., Sökmensüer C., et al. Endothelin receptor antagonist bosentan improves survival in a murine caecal ligation and puncture model of septic shock. Eur J Pharmacol 506 (2004) 83
8. Takala J. Determinants of splanchnic blood flow. Br J Anaesth 77 (1996) 50
9. Heyman S., Darmon D., Goldfarb M., et al. Endotoxin-induced renal failure. Exp Nephrol 8 (2000) 266
10. Wanecek M., Weitzberg E., Rudehill A., et al. The endothelin system in septic and endotoxic shock. Eur J Pharmacol 407 (2000) 1
11. B receptors on liver dysfunction and injury caused by endotoxaemia in the rat. Br J Pharmacol 119 (1996) 479
12. Iskit A.B., and Guc M.O. Effect of endothelin and nitric oxide on organ injury, mesenteric ischemia, and survival in experimental models of septic shock. Acta Pharmacol Sin 24 (2003) 953
13. Kilbourn R. The discovery of nitric oxide as a key mediator in septic shock. Sepsis 1 (1998) 85
14. Pittet J.F., Morel D.R., Hemsen A., et al. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 213 (1991) 261
15. Koksal G.M., Sayýlgan C., Aydýn S., et al. Correlation of plasma and tissue oxidative stresses in intra-abdominal sepsis. J Surg Res 122 (2004) 180
16. Bian K., and Murad F. Diversity of endotoxin-induced nitrotyrosine formation in macrophage-endothelium-rich organs. Free Rad Biol Med 31 (2001) 421
17. Ben-Saul V., Lomnitski L., Nyska A., et al. The effect of natural antioxidants, NAO and apocynin, on oxidative stress in the rat heart following LPS challenge. Toxicol Lett 123 (2001) 1
18. Sener G., Toklu H., Ercan F., et al. Protective effect of β-glucan against oxidative organ injury in rat model of sepsis. Int Immunopharmacol 5 (2005) 1387
19. Iseri S.O., Sener G., Saglam B., et al. Oxytocin protects against sepsis-induced multiple organ damage: Role of neutrophils. J Surg Res 126 (2005) 73
20. Kettle A.J., and Winterbourn C.C. Myeloperoxidase a key regulator of neutrophil oxidant production. Redox Rep 3 (1997) 3
21. Zimmerman B.J., Grisham M.B., and Granger D.N. Role of oxidants in ischemia-reperfusion induced granulocyte infiltration. Am J Physiol 258 (1990) G185
22. Clozel M., Ramuz H., Clozel J.P., et al. Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use. J Pharmacol Exp Ther 290 (1999) 840
23. Baykal A., Kavuklu B., Iskit A.B., et al. An experimental study of the effect of nitric oxide inhibition on mesenteric blood flow and interleukin-10 levels in lipopolysaccharide. World J Surg 24 (2000) 1116
24. Uchiyama M., and Mihara M. Determination of malondehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86 (1977) 271
25. Tietz F. Enzymic method of quantitative determination of nanogram amounts of total and oxidized glutathion: Applications to mammalian blood and other tissues. Anal Biochem 27 (1969) 502
26. Akbiyik F., Demirpençe E., Kuzu M.A., et al. In vitro and in vivo inhibition of myeloperoxidase with 5-fluorouracil. Eur J Clin Pharmacol 57 (2001) 631
27. Kingsley G.R. The direct biuret method for the determination of serum proteins as applied to photoelectric and visual colorimetry. J Lab Clin Med 27 (1942) 840
28. Guc M.O. Vascular responsiveness to vasoactive agents in endotoxaemia (1992), University of Strathclyde, Glasgow, United Kingdom Ph.D. Thesis
29. Winer B.J. Multifactor experiments having repeated measures on the same elements. In: Winer B.J. (Ed). Statistical Principles in Experimental Design (1972), McGraw-Hill, New York 514
30. Battistini B., Forget A.M., and Laight D. Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines. Shock 5 (1996) 167
31. Oldner A., Wanecek M., Weitzberg E., et al. Differentiated effects on splanchnic homeostasis by selective and non-selective endothelin receptor antagonism in porcine endotoxaemia. Br J Pharmacol 127 (1999) 1793
32. Ozaki S., Ohwaki K., Ihara M., et al. Coexpression studies with endothelin receptor subtypes indicate the existence of intracellular cross-talk between ET(A) and ET(B) receptors. J Biochem (Tokyo) 121 (1997) 440
33. Wanecek M., Oldner A., Sundin P., et al. Effects on haemodynamics by selective endothelin ET(B) receptor and combined endothelin ET(A)/ET(B) receptor antagonism during endotoxin shock. Eur J Pharmacol 386 (1999) 235
34. Iskit A.B., Sungur A., Gedikoglu G., et al. The effect of bosentan, aminoguanidine and L-canavanine on mesenteric blood flow, spleen and liver in endotoxaemic mice. Eur J Pharmacol 379 (1999) 73
35. Iskit A.B., and Guc M.O. A new therapeutic approach for the treatment of sepsis. Med Hypotheses 62 (2004) 342
36. Bauer M., Zhang J.X., Bauer I., et al. Endothelin-1 as a regulator of hepatic microcirculation: Sublobular distribution of effects and impact on hepatocellular secretory function. Shock 1 (1994) 457
37. Pannen B.H., Bauer M., Zhang J.X., et al. Endotoxin pretreatment enhances portal venous contractile response to endothelin-1. Am J Physiol 270 (1996) H7
38. Portoles M.T., Ainaga M.J., and Pagani R. The induction of lipid peroxidation by E. coli lipopolysaccharide on rat hepatocytes as an important factor in etiology of endotoxic liver damage. Biochim Biophys Acta 1158 (1993) 287
39. Novelli G.P. Role of free radical in septic shock. J Physiol Pharmacol 48 (1997) 517
40. Goode H.F., and Webster N.R. Free radicals and antioxidants in sepsis. Crit Care Med 21 (1993) 1770
41. Yilmaz G., Gursoy-Ozdemir Y., Dogan A.I., et al. Spleen damage in endotoxaemic mice: The involvement of nitric oxide. J Physiol Pharmacol 52 (2001) 729
42. Akinci S.B., Ulu N., Yondem O.Z., et al. Effect of neostigmine on organ injury in murine endotoxemia: missing facts about the cholinergic antiinflammatory pathway. World J Surg 29 (2005) 1483
43. Wichterman K.A., Baue A.E., and Chaudry I.H. Sepsis and septic shock: A review of laboratory models and a proposal. J Surg Res 29 (1980) 189